DEFA14A ·Filed Apr 27, 2026

BCAX

Bicara Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001628280-26-027321
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for any subsequent filings that might contain financial results or strategic announcements. The recent insider selling warrants attention but is not directly related to this proxy filing.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
BCAX ▲ +24.40% at T+60d
NEUTRAL call ✓ call won +24.40% · α vs SPY +19.63% · entry $22.48 → $27.96
Entry anchored
Apr 27, 06:43 AM ET
via exchange tick
T+1d
-2.47%
call -2.47% · α -1.98%
$21.92
settled 5mo ago
T+5d
+1.09%
call +1.09% · α +0.69%
$22.72
settled 5mo ago
T+20d
-2.20%
call -2.20% · α -7.16%
$21.98
settled 4mo ago
T+60d
+24.40%
call +24.40% · α +19.63%
$27.96
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Bicara Therapeutics Inc. filed a definitive proxy statement for a shareholder vote on director elections, executive compensation, and other corporate governance matters. The filing is routine and does not contain any material financial or strategic changes.

Key Facts

  • Filing is a DEFA14A, which is a definitive proxy statement for a shareholder meeting
  • No activist campaign or contested vote is indicated
  • Filing contains standard corporate governance items: director elections, executive compensation, auditor ratification
  • No financial figures or strategic changes are disclosed in the filing
  • Market data shows recent insider selling of $750K over 30 days

Financial Impact

No financial impact from this filing

Risk Factors

  • Insider selling could indicate lack of confidence, though this is not confirmed by this filing
  • No immediate financial or strategic impact from this routine proxy statement

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001628280-26-027321
Document: 0001628280-26-027321-index-headers.html0001628280-26-027321
Document: 0001628280-26-027321-index.html0001628280-26-027321
Document: 0001628280-26-027321.txt0001628280-26-027321
20 reports for BCAX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BCAX — sortable, filterable
TypeNow
Aug 25, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$24.73 $19.78▼ −20.02%▼ −20.24%$18.25 (−26.18%)
Aug 14, 2026
7w ago
Press Release
NEUTRAL ★ 2/10
$24.28 $23.20▼ −4.45%▼ −2.46%$18.25 (−24.81%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 5/10
$23.63 $22.81▼ −3.47%▼ −1.72%$18.25 (−22.75%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.63 $22.81▼ −3.47%▼ −1.72%$18.25 (−22.75%)
Aug 11, 2026
7w ago
8-K
MIXED ★ 6/10
$23.76 $23.64▼ −0.51%▲ +0.55%$18.25 (−23.17%)
Aug 11, 2026
7w ago
Press Release
MIXED ★ 6/10
$23.76 $23.64▼ −0.51%▲ +0.55%$18.25 (−23.17%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$28.10 $23.76▼ −15.44%▼ −17.94%$18.25 (−35.04%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$21.28 $29.68▼ −39.47%▼ −37.58%$18.25 (+14.22%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$21.58 $26.34▲ +22.06%▲ +23.96%$18.25 (−15.41%)
May 11, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$22.92 $20.56▼ −10.30%▼ −9.99%$18.25 (−20.35%)
Showing 10 of 20

US Market Status

Market Open — Closes in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access